Impact of Angiotensin II Receptor Blockers on Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction Based on Data from the Korean National Health Insurance Database (2005-2014).
Gwang Sil KimYoung-Guk KoYongsung SuhHoyoun WonSung Jin HongChul-Min AhnJung-Sun KimByeong-Keuk KimDoonghoon ChoiMeyong-Ki HongYang Soo JangPublished in: Korean circulation journal (2020)
ARB use was associated with a lower risk of MACE, MI, and revascularization than ACEIs in our retrospective analysis of AMI patients who underwent PCI.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- angiotensin ii
- health insurance
- st segment elevation myocardial infarction
- angiotensin converting enzyme
- st elevation myocardial infarction
- coronary artery disease
- acute coronary syndrome
- coronary artery bypass grafting
- antiplatelet therapy
- end stage renal disease
- newly diagnosed
- atrial fibrillation
- ejection fraction
- chronic kidney disease
- left ventricular
- vascular smooth muscle cells
- affordable care act
- healthcare
- prognostic factors
- coronary artery bypass
- emergency department
- patient reported outcomes
- cross sectional
- electronic health record
- peritoneal dialysis
- quality improvement
- heart failure
- data analysis
- drug induced